These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review. Qomara WF; Primanissa DN; Amalia SH; Purwadi FV; Zakiyah N Int J Gen Med; 2021; 14():8557-8571. PubMed ID: 34849001 [TBL] [Abstract][Full Text] [Related]
3. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review. Jomah S; Asdaq SMB; Al-Yamani MJ J Infect Public Health; 2020 Sep; 13(9):1187-1195. PubMed ID: 32773212 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571 [TBL] [Abstract][Full Text] [Related]
6. Directly Acting Antivirals for COVID-19: Where Do We Stand? Teoh SL; Lim YH; Lai NM; Lee SWH Front Microbiol; 2020; 11():1857. PubMed ID: 32849448 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
8. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Indari O; Jakhmola S; Manivannan E; Jha HC Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review. Gil Martínez V; Avedillo Salas A; Santander Ballestín S Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451833 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Hassaniazad M; Bazram A; Hassanipour S; Fathalipour M Trials; 2020 Oct; 21(1):886. PubMed ID: 33109246 [TBL] [Abstract][Full Text] [Related]
13. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Uzunova K; Filipova E; Pavlova V; Vekov T Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. Lai CC; Chao CM; Hsueh PR J Microbiol Immunol Infect; 2021 Oct; 54(5):767-775. PubMed ID: 34253490 [TBL] [Abstract][Full Text] [Related]
15. Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment. Sahin G; Akbal-Dagistan O; Culha M; Erturk A; Basarir NS; Sancar S; Yildiz-Pekoz A J Pharm Sci; 2022 Oct; 111(10):2652-2661. PubMed ID: 35691607 [TBL] [Abstract][Full Text] [Related]
16. An Update on Current Therapeutic Drugs Treating COVID-19. Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418 [TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2. Alabdalaali MM; Hadi AM Arch Razi Inst; 2023 Jun; 78(3):935-941. PubMed ID: 38028857 [TBL] [Abstract][Full Text] [Related]
18. Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Martinez MA Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of antivirals for Covid-19: A systematic review and meta-analysis. Prasad M; Elavarasi A; Madan K; Nischal N; Soneja M; Seth T; Sahoo RK; Sharma A; Garg P; Shalimar Natl Med J India; 2020; 33(4):222-231. PubMed ID: 34045377 [TBL] [Abstract][Full Text] [Related]